Fundz

Who to call at IceCure Medical, and when

Fundz watches for the moments IceCure Medical starts buying, and tells you who to reach.

  • An alert the day IceCure Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IceCure Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IceCure Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

IceCure Medical Enters Exclusive Distribution Agreement with Scovas for ProSense® Cryoablation Systems in the Netherlands.

Aug 24, 2026

Contract Type

agreement

CaesareaManufacturingBiotechnologyHealth CareMedicalMedical Devicemedical devices

Description

IceCure Medical Ltd. has signed an exclusive distribution agreement with Scovas Medical for its ProSense® cryoablation systems in the Netherlands. This agreement supports the commercialization and access to minimally invasive breast cancer treatments in the region as cryoablation technology advances.

Quick answer

IceCure Medical Enters Exclusive Distribution Agreement with Scovas for ProSense® Cryoablation Systems in the Netherlands. (August 24, 2026). IceCure Medical is based in Caesarea, Haifa District, Israel.

What agreement did IceCure Medical announce on August 24, 2026?
IceCure Medical Ltd. has signed an exclusive distribution agreement with Scovas Medical for its ProSense® cryoablation systems in the Netherlands. This agreement supports the commercialization and access to minimally invasive breast cancer treatments in the region as cryoablation technology advances.
What does IceCure Medical do?
IceCure Medical (NASDAQ: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being...
Where is IceCure Medical based?
IceCure Medical is based in Caesarea, Haifa District, Israel.

Source: Fundz verified event record.

Company Information

Company

IceCure Medical

Location

7 HaEshel Street

Caesarea, Haifa District, Israel

About

IceCure Medical (NASDAQ: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective option to surgical tumor removal that is easily performed in a relatively short procedure. The Company's flagship ProSense® system is marketed and sold worldwide for the indications cleared and approved to date including in the U.S., Europe and Asia.

Related People

Shay
Senior decision-maker at this company
••••••••@••••••••

See Shay's verified email →

Andrey
Senior decision-maker at this company
••••••••@••••••••

See Andrey's verified email →

Shad
Senior decision-maker at this company
••••••••@••••••••

See Shad's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for IceCure Medical's next move

Learn about Strategic plan

IceCure Medical signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.